AHA 2020

COVID-19 and Influenza

Fewer CV complications than expected in AHA COVID-19 Registry

Presented By

Prof. James de Lemos, University of Texas Southwestern Medical Center, USA

Trial

AHA COVID-19 CVD Registry

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:39

Worse COVID-19 outcomes in younger obese patients

Presented By

Dr Nicholas Hendren, University of Texas Southwestern, USA

Trial

AHA COVID-19 CVD Registry

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:28

Effects of CVD in hospitalised COVID-19 patients

Presented By

Prof. Ann Marie Navar, University of Texas Southwestern, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:22

Meta-analyses: ACEI/ARB and COVID-19

Presented By

Dr Yujiro Yokoyama, St. Luke's University Hospital

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:18

Unfavourable outcomes for COVID-19 patients with AF and atrial flutter

Presented By

Dr Zaniar Ghazizadeh, Brigham and Women’s Hospital, USA

Trial

Yale Cardiovascular COVID Registry

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 12:08

High-dose influenza vaccine in patients with CVD

Presented By

Prof. Orly Vardeny, University of Minnesota Medical School, USA

Trial

Phase 4, INVESTED

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 10:36

Atrial Fibrillation

CVD Risk Reduction

Clever trial design gets patients back on statins: the SAMSON trial

Presented By

Dr James Howard, Imperial College London, UK

Trial

SAMSON

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 15:10

Polypill plus aspirin reduces cardiovascular events

Presented By

Prof. Salim Yusuf, Population Health Research Institute, Canada

Trial

TIPS-3

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:58

Lowering LDL cholesterol in older patients is beneficial

Presented By

Dr Baris Gencer, Brigham and Women’s Hospital, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:54

No CV benefit from omega 3 in high-risk patients

Presented By

Prof. Michael Lincoff, Cleveland Clinic, USA

Trial

STRENGTH

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:44

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By

Prof. R. Scott Wright, Mayo Clinic, USA

Trial

Phase 3, ORION

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:37

Remote risk management programme effective and efficient

Presented By

Prof. Benjamin Scirica, Brigham and Women’s Hospital, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:31

Healthy lifestyle lowers mortality irrespective of medication burden

Presented By

Dr Neil Kelly, Weill Cornell University, USA

Trial

REGARDS

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:24

Heart Failure

Acute Coronary Syndrome

Coronary and Valve Disease

Stroke

Miscellaneous

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By

Dr Connie Hess; Prof. Judith Hsia

Trial

VOYAGER PAD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:45

Sotatercept: potential new treatment option for PAH

Presented By

Prof. Vallerie McLaughlin, University of Michigan, USA

Trial

Phase 2, PULSAR

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:37

Finerenone lowers CV events in diabetic CKD patients

Presented By

Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:33

Mavacamten effective in obstructive hypertrophic cardiomyopathy

Presented By

Dr Sheila Hegde, Brigham and Women’s Hospital, USA

Trial

Phase 3, EXPLORER-HCM

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:28

Children exposed to tobacco smoke have worse heart function as adults

Presented By

Dr Chigozie Ezegbe, University of Tasmania, Australia

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:25

Transgender people have unaddressed heart disease risks

Presented By

Dr Kara Denby, Cleveland Clinic, USA

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:23

Rilonacept reduces risk of pericarditis recurrence

Presented By

Dr Alan Klein, Cleveland Clinic, USA

Trial

Phase 3, RHAPSODY

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:18

Intensive blood pressure lowering benefits older adults

Presented By

Prof. William Cushman, University of Tennessee Health Science, USA

Trial

SPRINT

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:13

Dobutamine versus milrinone in cardiogenic shock

Trial

Capital Do-Re-Mi

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:10

Longer chest compression pause worsens outcomes after paediatric IHCA

Presented By

Dr Kasper Glerup Lauridsen, Aarhus University, Denmark

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:06